460 related articles for article (PubMed ID: 29906613)
1. Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-κB) signaling in cancer cells.
Senga S; Kobayashi N; Kawaguchi K; Ando A; Fujii H
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1057-1067. PubMed ID: 29906613
[TBL] [Abstract][Full Text] [Related]
2. The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis.
Kawaguchi K; Kinameri A; Suzuki S; Senga S; Ke Y; Fujii H
Biochem J; 2016 Feb; 473(4):449-61. PubMed ID: 26614767
[TBL] [Abstract][Full Text] [Related]
3. Utilization of adipocyte-derived lipids and enhanced intracellular trafficking of fatty acids contribute to breast cancer progression.
Yang D; Li Y; Xing L; Tan Y; Sun J; Zeng B; Xiang T; Tan J; Ren G; Wang Y
Cell Commun Signal; 2018 Jun; 16(1):32. PubMed ID: 29914512
[TBL] [Abstract][Full Text] [Related]
4. FABP5 coordinates lipid signaling that promotes prostate cancer metastasis.
Carbonetti G; Wilpshaar T; Kroonen J; Studholme K; Converso C; d'Oelsnitz S; Kaczocha M
Sci Rep; 2019 Dec; 9(1):18944. PubMed ID: 31831821
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor delta facilitates lipid secretion and catabolism of fatty acids in dairy goat mammary epithelial cells.
Shi HB; Zhang CH; Zhao W; Luo J; Loor JJ
J Dairy Sci; 2017 Jan; 100(1):797-806. PubMed ID: 27865496
[TBL] [Abstract][Full Text] [Related]
6. FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism.
Zhang C; Liao Y; Liu P; Du Q; Liang Y; Ooi S; Qin S; He S; Yao S; Wang W
Theranostics; 2020; 10(15):6561-6580. PubMed ID: 32550890
[TBL] [Abstract][Full Text] [Related]
7. Aberrant DNA methylation-mediated NF-κB/fatty acid-binding protein 5 (FABP5) feed-forward loop promotes malignancy of colorectal cancer cells.
Kawaguchi K; Ohashi T; Kobayashi N; Kanemoto K; Nose M; Shinozaki R; Kataoka T; Fujii H
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Sep; 1868(9):159362. PubMed ID: 37414211
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of SREBP1 (sterol regulatory element binding protein 1) promotes de novo fatty acid synthesis and triacylglycerol accumulation in goat mammary epithelial cells.
Xu HF; Luo J; Zhao WS; Yang YC; Tian HB; Shi HB; Bionaz M
J Dairy Sci; 2016 Jan; 99(1):783-95. PubMed ID: 26601584
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter.
Forootan FS; Forootan SS; Gou X; Yang J; Liu B; Chen D; Al Fayi MS; Al-Jameel W; Rudland PS; Hussain SA; Ke Y
Oncotarget; 2016 Feb; 7(8):9322-39. PubMed ID: 26814431
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid-binding protein 5 controls microsomal prostaglandin E synthase 1 (mPGES-1) induction during inflammation.
Bogdan D; Falcone J; Kanjiya MP; Park SH; Carbonetti G; Studholme K; Gomez M; Lu Y; Elmes MW; Smietalo N; Yan S; Ojima I; Puopolo M; Kaczocha M
J Biol Chem; 2018 Apr; 293(14):5295-5306. PubMed ID: 29440395
[TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
12. Aspirin suppresses the abnormal lipid metabolism in liver cancer cells via disrupting an NFκB-ACSL1 signaling.
Yang G; Wang Y; Feng J; Liu Y; Wang T; Zhao M; Ye L; Zhang X
Biochem Biophys Res Commun; 2017 May; 486(3):827-832. PubMed ID: 28359761
[TBL] [Abstract][Full Text] [Related]
13. FABP5 enhances malignancies of lower-grade gliomas via canonical activation of NF-κB signaling.
Wang Y; Wahafu A; Wu W; Xiang J; Huo L; Ma X; Wang N; Liu H; Bai X; Xu D; Xie W; Wang M; Wang J
J Cell Mol Med; 2021 May; 25(9):4487-4500. PubMed ID: 33837625
[TBL] [Abstract][Full Text] [Related]
14. Activation of nucleotide oligomerization domain containing protein 1 induces lipolysis through NF-κB and the lipolytic PKA activation in 3T3-L1 adipocytes.
Purohit JS; Hu P; Chen G; Whelan J; Moustaid-Moussa N; Zhao L
Biochem Cell Biol; 2013 Dec; 91(6):428-34. PubMed ID: 24219284
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability.
Powell CA; Nasser MW; Zhao H; Wochna JC; Zhang X; Shapiro C; Shilo K; Ganju RK
Oncotarget; 2015 Mar; 6(8):6373-85. PubMed ID: 25779666
[TBL] [Abstract][Full Text] [Related]
16. Epidermal FABP (FABP5) regulates keratinocyte differentiation by 13(S)-HODE-mediated activation of the NF-κB signaling pathway.
Ogawa E; Owada Y; Ikawa S; Adachi Y; Egawa T; Nemoto K; Suzuki K; Hishinuma T; Kawashima H; Kondo H; Muto M; Aiba S; Okuyama R
J Invest Dermatol; 2011 Mar; 131(3):604-12. PubMed ID: 21068754
[TBL] [Abstract][Full Text] [Related]
17. FABP5 is a critical regulator of methionine- and estrogen-induced SREBP-1c gene expression in bovine mammary epithelial cells.
Li P; Yu M; Zhou C; Qi H; Wen X; Hou X; Li M; Gao X
J Cell Physiol; 2018 Jan; 234(1):537-549. PubMed ID: 30071125
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of long-chain acyl-CoA synthetase 1 in 3T3-L1 adipocytes.
Lobo S; Wiczer BM; Bernlohr DA
J Biol Chem; 2009 Jul; 284(27):18347-56. PubMed ID: 19429676
[TBL] [Abstract][Full Text] [Related]
19. Pterostilbene Inhibits Adipocyte Conditioned-Medium-Induced Colorectal Cancer Cell Migration through Targeting FABP5-Related Signaling Pathway.
Hsiao YH; Chen NC; Koh YC; Nagabhushanam K; Ho CT; Pan MH
J Agric Food Chem; 2019 Sep; 67(37):10321-10329. PubMed ID: 31419115
[TBL] [Abstract][Full Text] [Related]
20. FABP5 is correlated with poor prognosis and promotes tumour cell growth and metastasis in clear cell renal cell carcinoma.
Wu G; Xu Y; Wang Q; Li J; Li L; Han C; Xia Q
Eur J Pharmacol; 2019 Nov; 862():172637. PubMed ID: 31491402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
